Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared to approved monthly maintenance d
This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials New data show
2 Things Investors Should Know About Eli Lilly's $5 Billion Investment to Improve Its Drug Production Capacity
05:15am, Friday, 24'th Oct 2025
Eli Lilly's new U.S. facility will be just the first of four that it plans to build in the country. The company expects to eventually make 100% of drugs for American patients in the U.S.
Best Medical Stocks To Research – October 22nd
02:50am, Friday, 24'th Oct 2025
Intuitive Surgical, UnitedHealth Group, Eli Lilly and Company, Boston Scientific, Thermo Fisher Scientific, Hims and Hers Health, and Danaher are the seven Medical stocks to watch today, according to
Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?
11:40am, Thursday, 23'rd Oct 2025
Lilly stock climbs nearly 10% in a month amid a broader recovery in the drug and biotech sector.
Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?
11:06am, Thursday, 23'rd Oct 2025
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly Accelerates On Obesity Data While Novo Nordisk Retreats
08:00am, Thursday, 23'rd Oct 2025
Eli Lilly is a Strong Buy, driven by exceptional growth in obesity and diabetes drugs Mounjaro and Zepbound, plus pipeline innovation. LLY's diversified business mix, global reach, and proactive U.S.
Eli Lilly allows Cipla to sell weight loss drug under new brand in India
06:37am, Thursday, 23'rd Oct 2025
Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday.
Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager
08:36am, Wednesday, 22'nd Oct 2025
Sold 6,430 shares of Eli Lilly and Company; estimated transaction value ~$4.78 million Post-trade holding: 61,292 shares valued at $46.77 million Position now 1% of fund AUM, which places it outside t
3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report
03:43am, Wednesday, 22'nd Oct 2025
Eli Lilly is expected to present third-quarter results on Oct. 30 after the market opens. Wall Street analysts will be looking closely at sales growth for Mounjaro and Zepbound.
Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
04:26pm, Tuesday, 21'st Oct 2025
But if you have $1,000 to put into the market, there are several quality names that offer significant upside even though—in some cases—they've outperformed the market in 2025. In other words, if y
Eli Lilly Q3 earnings eyed for insights into drug pricing policies, obesity and diabetes drug performance
01:09pm, Monday, 20'th Oct 2025
Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely watching how the company's obesity and diabetes treatments are performing a
My Top 3 Pharma Stocks
11:38am, Monday, 20'th Oct 2025
Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off the radars of many investors. Many of them consistently beat the Street's consensus estimates and o
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 20'th Oct 2025
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Medical Stocks Worth Watching – October 18th
01:40am, Monday, 20'th Oct 2025
Hims and Hers Health, Eli Lilly and Company, UnitedHealth Group, Gilead Sciences, AbbVie, Johnson and Johnson, and Thermo Fisher Scientific are the seven Medical stocks to watch today, according to Ma
